(Q44936850)

7 December 2017

Effective doses of ibandronate do not influence the 3-year progression of aortic calcification in elderly osteoporotic women (English)

1 reference

7 December 2017

0 references

László B Tankó

1

1 reference

7 December 2017

Gerong Qin

2

1 reference

7 December 2017

Peter Alexandersen

3

1 reference

7 December 2017

Yu Z Bagger

4

1 reference

7 December 2017

Claus Christiansen

5

1 reference

7 December 2017

language of work or name

English

0 references

publication date

10 June 2004

1 reference

Osteoporosis International

7 December 2017

1 reference

7 December 2017

16

1 reference

7 December 2017

2

1 reference

7 December 2017

184-190

1 reference

https://scigraph.springernature.com/pub.10.1007/s00198-004-1662-x

7 December 2017

0 references

cites work

Carotid intima-media wall thickness in elderly women with and without atherosclerosis of the abdominal aorta

1 reference

12 December 2020

Low Bone Mineral Density in the Hip as a Marker of Advanced Atherosclerosis in Elderly Women

1 reference

12 December 2020

Bone mineral density and the risk of peripheral arterial disease: the Rotterdam Study

1 reference

12 December 2020

Bone loss and the progression of abdominal aortic calcification over a 25 year period: the Framingham Heart Study

1 reference

12 December 2020

Transesophageal echocardiographically detected atherosclerotic aortic plaque is a marker for coronary artery disease

1 reference

12 December 2020

Vascular calcification and its relation to bone calcification: possible underlying mechanisms.

1 reference

12 December 2020

Progression of aortic calcification is associated with metacarpal bone loss during menopause: a population-based longitudinal study

1 reference

12 December 2020

Oral ibandronate: changes in markers of bone turnover during adequately dosed continuous and weekly therapy and during different suboptimally dosed treatment regimens

1 reference

12 December 2020

Intravenous ibandronate injections given every three months: a new treatment option to prevent bone loss in postmenopausal women

1 reference

12 December 2020

Bisphosphonate therapy and vascular calcification

1 reference

12 December 2020

Aortic calcification contributing to bone densitometry measurement

1 reference

12 December 2020

Bone mineral density and blood flow to the lower extremities: the study of osteoporotic fractures.

1 reference

12 December 2020

Coronary calcification: insights from sudden coronary death victims

1 reference

12 December 2020

Daily and intermittent oral ibandronate normalize bone turnover and provide significant reduction in vertebral fracture risk: results from the BONE study

1 reference

12 December 2020

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

1 reference

12 December 2020

The association between low bone mass at the menopause and cardiovascular mortality

1 reference

12 December 2020

Long-term therapy for postmenopausal osteoporosis: stronger bones but weaker arteries

1 reference

12 December 2020

Cardiovascular disease and osteoporosis: is there a link between lipids and bone?

1 reference

12 December 2020

Alendronate has a residual effect on bone mass in postmenopausal Danish women up to 7 years after treatment withdrawal.

1 reference

12 December 2020

Bisphosphonates alendronate and ibandronate inhibit artery calcification at doses comparable to those that inhibit bone resorption

1 reference

12 December 2020

Ibandronate: a potent new bisphosphonate in the management of postmenopausal osteoporosis.

1 reference

12 December 2020

Bisphosphonates and atherosclerosis

1 reference

12 December 2020

New indices to classify location, severity and progression of calcific lesions in the abdominal aorta: a 25-year follow-up study

1 reference

12 December 2020

Progression of coronary artery calcification in patients taking alendronate for osteoporosis

1 reference

12 December 2020

Extracoronary atherosclerotic plaque at multiple sites and total coronary calcification deposit in asymptomatic men. Association with coronary risk profile.

1 reference

12 December 2020

Bisphosphonate treatment of osteoporosis

1 reference

12 December 2020

10.1007/S00198-004-1662-X

Identifiers

DOI

1 reference

release_wmycd466tzcnlhd26hefe5bpha

7 December 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/wmycd466tzcnlhd26hefe5bpha

24 November 2022

mapped directly with Wikidata item

1 reference